- At a Glance
- Strategy & Targets
- Reports
- ESG Ratings and Rankings
- Climate, Environment and Safety
- People
-
Governance
- Bayer Sustainability Council
- Bayer Bioethics Council
- Stakeholder Dialogue
- UN Global Compact
-
Group Positions
- BASE
- Bioethical Principles
- Protection of Biodiversity
- Position on Global Product Strategy
- Position on Responsible Care
- Position on Deforestation and Forest Degradation
- Position on Insect Decline
- Raising the Bar on Crop Protection Safety Standards
- UN Sustainable Development Goals
- Position on Sustainable Beef Production
- Supplier Management
- Group Regulations
- Transparency
- Societal Engagement
Data Disclosure
In accordance with the EFPIA Disclosure Code Bayer discloses transfers of value connected to the development and commercialization of prescription-only human pharmaceuticals to healthcare professionals and healthcare organizations.
The disclosed data include transfers of value in four main categories
Categories |
Transfers of value |
|
---|---|---|
Healthcare Professionals |
Healthcare Organizations |
|
Donations and grants |
Whether monetary or other | |
Events |
|
|
Services and consultancy |
|
|
Research and development |
Fees, travel & accommodation, and other related expenses that are covered in connection with the service |
We at Bayer confirm that our disclosures of transfers of value (ToVs) to HCPs and HCOs have been reported in application of the EFPIA Disclosure Code key principles.
Get Access to the National Data Disclosure
According to the EFPIA Disclosure Code payments, in the majority of countries in Europe, are disclosed on Bayer company global and local websites. In that case links accessible from the list above will be leading directly to the respective country’s data disclosure report available in English and local language.
In other countries, due to the either existing national legislation or legislation in development and country self-regulation, often in partnership with stakeholders, disclosure is required on a central online platform. In that case above links will be leading to the respective country’s disclosure section on the Bayer company local webpage enabling further information.